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Background
The Caribbean, Central and South America network
(CCASAnet) is one of seven regions funded by the Inter-
national Epidemiologic Databases to Evaluate AIDS
(IeDEA) program sponsored by the National Institute of
Allergy & Infectious Diseases and National Cancer Insti-
tute [1]. CCASAnet performs analyses using HIV epidemi-
ology data from clinical care sites in Argentina, Brazil,
Chile, Haiti, Honduras, Mexico and Peru. In August of
2007, with a funding supplement provided by NCI, six
participating sites in the network began a project to deter-
mine the incidence, treatment and outcomes of cancer
occurring in HIV-infected individuals in the region.
Methods
A total of approximately 13,000 HIV-positive individuals
followed at the participating sites formed the study
cohort. Chart reviews began in fall 2007 and are continu-
ing at present. A standardized cancer case abstract form
was developed by the Vanderbilt data coordination center
and its use was validated by Fundación Huésped in Bue-
nos Aires. English and Spanish language versions of the
case report form and instructions for its use were created,
along with a secure online Web interface for capturing
data in computerized format, Table 1.
Conclusion
The preliminary incidence and cancer types occurring in
selected cohorts in the Caribbean, Central and South
America are consistent with previously reported cancer
findings in HIV-infected populations.
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Table 1: Preliminary results *
Site – Country FH – Argentina UFRJ – Brazil FA – Chile GHESKIO – Haiti IHSS – Honduras
Total adult patients 2000 2800 2400 4000 1000
Adult patients 
reviewed to date for 
cancer diagnoses
1200 620 2400 450 946
Cancer cases 
identified as of May, 
2008
107 36 125 27 51
Current cancer 
incidence estimate in 
HIV cohort
8.9% 5.8% 5.2% 6% 5.4%

























4 in situ cervical 
neoplasias (CIN),
1 non KS sarcoma,















Case reviews and 
confirmations in 
progress. To date, 5 
NHL cases found (2 
Burkitt, 1 small cell, 2 
NHL not otherwise 
specified)
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